A Clinicopathologic Study of 24 Cases of Systemic Mastocytosis Involving the Gastrointestinal Tract and Assessment of Mucosal Mast Cell Density in Irritable Bowel Syndrome and Asymptomatic Patients

作者
Leona A. Doyle,Golrokh J. Sepehr,Matthew J. Hamilton,Cem Akin,Mariana Castells,Jason L. Hornick
出处
期刊:The American Journal of Surgical Pathology [Lippincott Williams & Wilkins]
卷期号:38 (6): 832-843 被引量:160
标识
DOI:10.1097/pas.0000000000000190
摘要

Counting mast cells in gastrointestinal (GI) mucosal biopsies is becoming an increasingly common practice. The primary reason for this exercise is to evaluate for possible involvement by systemic mastocytosis (SM). However, the features of mastocytosis in GI biopsies are not well described. In addition, recent studies have suggested that increased mast cells may be involved in the pathogenesis of some cases of diarrhea-predominant irritable bowel syndrome (IBS); the term "mastocytic enterocolitis" has been proposed for such cases. As the baseline mast cell density in colonic biopsies from normal patients has not been established in large cohorts, there is no widely accepted threshold for what constitutes increased mucosal mast cells. The aims of this study were (1) to determine the utility of GI biopsies for the diagnosis of SM, (2) to characterize the clinical, histologic, and immunohistochemical features of mastocytosis in the GI tract, (3) to determine mast cell density in normal colonic mucosa from a large cohort of asymptomatic patients, and (4) to compare these findings with those from patients with diarrhea-predominant IBS. Twenty-four patients with SM involving the GI tract, 100 asymptomatic patients, and 100 patients with IBS (the latter 2 groups with histologically normal colonic biopsies) were included. For the mastocytosis group, 107 biopsies (70 involved by mastocytosis; 67 mucosal, 3 liver) from 20 women and 4 men were evaluated (median age 59 y). The most commonly involved site was the colon (19 patients, 95%), followed by ileum (86%), duodenum (80%), and stomach (54%). In 16 cases (67%), the first diagnosis of SM was made on the basis of GI biopsies. Seventeen patients had documented cutaneous mastocytosis. Fifteen of 17 patients who underwent bone marrow biopsy had marrow involvement by SM. Eighteen patients had indolent disease, and 6 had aggressive disease (including all 3 with liver involvement). The most common GI symptom was diarrhea, followed by abdominal pain, nausea, weight loss, bloating, vomiting, or reflux. Liver disease presented with hepatomegaly and ascites. Endoscopic abnormalities (observed in 62%) included erythema, granularity, and nodules. Histologically, involved biopsies were characterized by infiltrates of ovoid to spindle-shaped mast cells in aggregates or sheets in the lamina propria, sometimes forming a confluent band underneath the surface epithelium; 25% of biopsies had only focal involvement (single aggregate). Prominent eosinophils were seen in 44% of involved colonic/ileal biopsies and 16% of duodenal biopsies. Mast cells were highlighted by diffuse membranous staining for KIT and CD25. In the nonmastocytosis groups, all biopsies contained singly dispersed mast cells with no aggregates. The mean highest mast cell counts (in a single high-power field) for asymptomatic patients and IBS patients were 26 (range, 11 to 55) and 30 (range, 13 to 59), respectively. In summary, GI (especially colonic) biopsies can establish a diagnosis of SM in patients with GI symptoms. GI involvement is usually subtle and is often associated with prominent eosinophils, which may obscure the mast cell infiltrate. KIT and CD25 are invaluable markers for the diagnosis. Mast cell density in colonic mucosa from asymptomatic patients is highly variable. Although patients with diarrhea-predominant IBS on average have mildly increased mast cells, the overlap in range with that of control patients is too great for this difference to be clinically useful. These findings argue against the utility of counting GI mucosal mast cell in patients with chronic diarrhea.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
CarryLJR发布了新的文献求助10
刚刚
会盟发布了新的文献求助10
刚刚
刚刚
zs关闭了zs的文献求助
1秒前
DavidSun完成签到,获得积分10
1秒前
wwwww完成签到,获得积分10
1秒前
上官若男的应助被Loooong采纳,获得10
2秒前
3秒前
3秒前
晨昏蒙影完成签到 ,获得积分10
3秒前
NL完成签到,获得积分10
3秒前
勤劳的尔丝完成签到 ,获得积分10
4秒前
4秒前
Orange的应助被Arjun采纳,获得50
5秒前
铁头霸霸完成签到 ,获得积分10
5秒前
zest完成签到,获得积分10
5秒前
Yolo发布了新的文献求助10
6秒前
agathahqs的应助被ly普鲁卡因采纳,获得10
6秒前
陶醉孤云完成签到 ,获得积分10
7秒前
矛盾空间完成签到,获得积分10
8秒前
苏信怜完成签到,获得积分10
8秒前
8秒前
小雨完成签到,获得积分10
9秒前
岁岁平安完成签到,获得积分10
9秒前
碧蓝丹烟完成签到,获得积分10
9秒前
JonyJie完成签到,获得积分10
9秒前
pretender_lu完成签到,获得积分10
9秒前
moca完成签到,获得积分10
9秒前
cdercder的应助被科研通管家采纳,获得30
9秒前
一支菜馅儿馄饨完成签到,获得积分10
10秒前
just do it完成签到,获得积分10
10秒前
10秒前
pariscxl完成签到,获得积分10
11秒前
一只橙子完成签到,获得积分10
11秒前
h11的应助被熵生记采纳,获得10
11秒前
12秒前
12秒前
zgxj完成签到,获得积分10
13秒前
某某完成签到,获得积分10
14秒前
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159151
求助须知:如何正确求助?哪些是违规求助? 9554617
关于积分的说明 21719982
捐赠科研通 7748814
什么是DOI,文献DOI怎么找? 3427149
关于科研通互助平台的介绍 2552091
邀请新用户注册赠送积分活动 2471436